Biotricity (BTCY) Institutional Ownership → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free BTCY Stock Alerts $1.08 +0.02 (+1.89%) (As of 06/7/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Biotricity (NASDAQ:BTCY)CurrentInstitutional OwnershipPercentage3.89%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$117.02KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$962.42K Get BTCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Biotricity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BTCY Institutional Buying and Selling by Quarter Ad The Freeport SocietyBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. Biotricity Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/19/2024 Advisor Resource Council79,070$117K0.0%N/A0.839% 10/30/2023 Strengthening Families & Communities LLC48,263$103K0.0%-83.3%0.563% 10/11/2023 AE Wealth Management LLC41,684$89K0.0%-83.3%0.486% (Data available from 1/1/2016 forward) BTCY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BTCY shares? During the previous two years, the following institutional investors and hedge funds held shares of Biotricity shares: Advisor Resource Council ($117K), and Strengthening Families & Communities LLC ($103K), AE Wealth Management LLC ($89K).Learn more on BTCY's institutional investors. What percentage of Biotricity stock is owned by institutional investors? 3.89% of Biotricity stock is owned by institutional investors. Learn more on BTCY's institutional investor holdings. Which institutional investors have been buying Biotricity stock? The following institutional investors have purchased Biotricity stock in the last 24 months: Advisor Resource Council ($79.07K). How much institutional buying is happening at Biotricity? Institutional investors have bought a total of 79,070 shares in the last 24 months. This purchase volume represents approximately $117.02K in transactions. Which Biotricity major shareholders have been selling company stock? The following institutional investors have sold Biotricity stock in the last 24 months: Strengthening Families & Communities LLC ($241.31K), and AE Wealth Management LLC ($208.42K). How much institutional selling is happening at Biotricity? Institutional investors have sold a total of 449,728 shares in the last 24 months. This volume of shares sold represents approximately $962.42K in transactions. Related Companies: DarioHealth Major Shareholders Beyond Air Major Shareholders iCAD Major Shareholders Modular Medical Major Shareholders Akili Major Shareholders Co-Diagnostics Major Shareholders Spectral AI Major Shareholders T2 Biosystems Major Shareholders Inspira Technologies Oxy B.H.N. Major Shareholders NeuroOne Medical Technologies Major Shareholders This page (NASDAQ:BTCY) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.